| Date | Time | Source | Headline | Symbol | Company |
| 12/12/2023 | 10:56AM | Alliance News |  TRADING UPDATES: Technology Minerals identifies lithium at Knockeen | LSE:MXCT | Maxcyte Inc |
| 12/12/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. CEO Transition and Revenue Guidance Update | LSE:MXCT | Maxcyte Inc |
| 12/07/2023 | 4:50AM | UK Regulatory | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
| 12/04/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
| 12/01/2023 | 12:43PM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 11/30/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
| 11/17/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
| 11/16/2023 | 8:05AM | RNS Non-Regulatory | MaxCyte, Inc. MaxCyte Joins the Alliance for mRNA Medicines | LSE:MXCT | Maxcyte Inc |
| 11/09/2023 | 9:14AM | Alliance News | EARNINGS AND TRADING: Chapel Down hopes to make splash on AIM | LSE:MXCT | Maxcyte Inc |
| 11/09/2023 | 2:01AM | UK Regulatory | MaxCyte, Inc. Filing of Form 10-Q | LSE:MXCT | Maxcyte Inc |
| 11/09/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. Third Quarter Results | LSE:MXCT | Maxcyte Inc |
| 11/07/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. Participation in Upcoming Investor Conferences | LSE:MXCT | Maxcyte Inc |
| 11/01/2023 | 9:12AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 10/05/2023 | 5:08AM | Alliance News | MaxCyte shares fall as warns of sharp revenue drop, citing volatility | LSE:MXCT | Maxcyte Inc |
| 10/05/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. Preliminary Q3 Revenue & FY Revenue Guidance | LSE:MXCT | Maxcyte Inc |
| 10/02/2023 | 11:03AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 09/13/2023 | 9:28AM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 09/12/2023 | 8:21AM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 09/06/2023 | 8:05AM | RNS Non-Regulatory | MaxCyte, Inc. Appointment of Executive VP of Bioprocessing | LSE:MXCT | Maxcyte Inc |
| 09/05/2023 | 11:17AM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 09/05/2023 | 8:05AM | UK Regulatory | MaxCyte, Inc. Baird Global Healthcare Conference Participation | LSE:MXCT | Maxcyte Inc |
| 09/04/2023 | 8:32AM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 09/04/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 09/01/2023 | 4:01AM | UK Regulatory | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
| 08/18/2023 | 12:25PM | UK Regulatory | MaxCyte, Inc. TR-1 | LSE:MXCT | Maxcyte Inc |
| 08/17/2023 | 11:27AM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
| 08/17/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. TR-1: Notification of Major Holdings | LSE:MXCT | Maxcyte Inc |
| 08/10/2023 | 5:22AM | Alliance News | MaxCyte shares fall as revenue plummets in first half, loss widens | LSE:MXCT | Maxcyte Inc |
| 08/10/2023 | 2:25AM | UK Regulatory | MaxCyte, Inc. Filing of Form 10-Q | LSE:MXCT | Maxcyte Inc |
| 08/10/2023 | 2:00AM | UK Regulatory | MaxCyte, Inc. Second Quarter and Half-Year Results | LSE:MXCT | Maxcyte Inc |